Követés
Sachchidanand Tiwari
Sachchidanand Tiwari
Perelman School of Medicine, University of Pennsylvania; IIT-Delhi; DTU
E-mail megerősítve itt: pennmedicine.upenn.edu
Cím
Hivatkozott rá
Hivatkozott rá
Év
Biofunctionalized nanostructured zirconia for biomedical application: a smart approach for oral cancer detection
S Kumar, S Kumar, S Tiwari, S Srivastava, M Srivastava, BK Yadav, ...
Advanced Science 2 (8), 1500048, 2015
1302015
Highly Sensitive Protein Functionalized Nanostructured Hafnium Oxide Based Biosensing Platform for Non-invasive Oral Cancer Detection
BDM Suveen Kumar, Saurabh Kumar, Sachchidanand Tiwari, Shine Augustine ...
Sensors and Actuators B: Chemical, 2016
1102016
L-cysteine capped lanthanum hydroxide nanostructures for non-invasive detection of oral cancer biomarker
S Tiwari, PK Gupta, Y Bagbi, T Sarkar, PR Solanki
Biosensors and Bioelectronics 89 (Part 2), 1042-1052, 2017
1082017
Bismuth oxide nanorods based immunosensor for mycotoxin detection
PR Solanki, J Singh, B Rupavali, S Tiwari, BD Malhotra
Materials Science and Engineering: C 70, 564-571, 2017
522017
Synthesis of l-cysteine stabilized zero-valent iron (nZVI) nanoparticles for lead remediation from water
Y Bagbi, A Sarswat, S Tiwari, D Mohan, A Pandey, PR Solanki
Environmental Nanotechnology, Monitoring & Management 7, 34-45, 2017
512017
Amino acid functionalized ZrO 2 nanoparticles decorated reduced graphene oxide based immunosensor
PK Gupta, S Tiwari, ZH Khan, PR Solanki
Journal of Materials Chemistry B 5 (10), 2019-2033, 2017
452017
Nanoscale zero-valent iron for aqueous lead removal
Y Bagbi, A Sarswat, S Tiwari, D Mohan, A Pandey, PR Solanki
Adv. Mater. Proc 2 (4), 235-241, 2017
192017
Polylactic acid based polymeric nanoparticle mediated co-delivery of navitoclax and decitabine for cancer therapy
N Mehrotra, M Anees, S Tiwari, S Kharbanda, H Singh
Nanomedicine: Nanotechnology, Biology and Medicine 47, 102627, 2023
152023
Hydrophilic, fluorescent and superparamagnetic iron oxide-carbon composite nanoparticles
T Sarkar, S Tiwari, K Rawat, PR Solanki, HB Bohidar
Colloids and Surfaces A: Physicochemical and Engineering Aspects 514, 218-225, 2017
142017
Polylactic acid based biodegradable hybrid block copolymeric nanoparticle mediated co-delivery of salinomycin and doxorubicin for cancer therapy
M Anees, N Mehrotra, S Tiwari, D Kumar, S Kharbanda, H Singh
International Journal of Pharmaceutics 635, 122779, 2023
112023
Development and evaluation of PLA based hybrid block copolymeric nanoparticles for systemic delivery of pirarubicin as an anti-cancer agent
M Anees, S Tiwari, N Mehrotra, S Kharbanda, H Singh
International Journal of Pharmaceutics 620, 121761, 2022
82022
Marginated neutrophils in the lungs effectively compete for nanoparticles targeted to the endothelium, serving as a part of the reticuloendothelial system
ME Zamora, EO Essien, K Bhamidipati, A Murthy, J Liu, H Kim, MN Patel, ...
ACS nano 18 (33), 22275-22297, 2024
52024
Quatramer™ encapsulation of dual‐targeted PI3‐Kδ/HDAC6 inhibitor, HSB‐510, suppresses growth of breast cancer
S Tiwari, S Liu, M Anees, N Mehrotra, A Thakur, GJ Tawa, G Grewal, ...
Bioengineering & Translational Medicine 8 (5), e10541, 2023
32023
Co-encapsulation of PI3-Kδ/HDAC6 dual inhibitor and Navitoclax in Quatramer™ nanoparticles for synergistic effect in ER+ breast cancer
S Tiwari, H Kaur, M Anees, P Gupta, M Dalela, S Kharbanda, H Singh
International Journal of Pharmaceutics 628, 122343, 2022
32022
Emerging Aid in Oral Cancer Diagnosis
S Tiwari, P Solanki
J Mol Biomark Diagn 6 (5), 1000e122, 2015
32015
Enabling non-viral DNA delivery using lipid nanoparticles co-loaded with endogenous anti-inflammatory lipids
MN Patel, S Tiwari, Y Wang, S O’Neill, J Wu, S Omo-Lamai, C Espy, ...
BioRxiv, 2024
22024
Pluronic modified PLA based hybrid block copolymeric nanoformulation enhanced anti-cancer therapeutic efficacy of Epirubicin
S Tiwari, P Gupta, M Anees, H Kaur, S Kharbanda, H Singh
European Polymer Journal 193, 112084, 2023
22023
Novel iron-mediated cell death (Ferroptosis) inducer, HSB-1216, suppress acute myeloid leukemia growth
S Kharbanda, S Liu, S Tiwari, A Mohammad, E Weisberg, H Singh, ...
European Journal of Cancer 174, S51, 2022
22022
Quatramer™ mediated co-delivery of PI3-Kδ/HDAC6 dual inhibitor augments the anti-cancer efficacy of Epirubicin in breast cancer
S Tiwari, S Kharbanda, H Singh
European Journal of Pharmaceutics and Biopharmaceutics 179, 184-193, 2022
22022
Novel quatramer nano-formulation of dual-targeted PI3-Kδ/HDAC6 inhibitor, HSB-510, suppresses growth of triple negative breast cancer
S Tiwari, S Liu, M Anees, N Mehrotra, A Thakur, G Tawa, G Grewal, ...
Cancer Research 82 (12_Supplement), 5406-5406, 2022
22022
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20